11-5788014-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001001913.2(OR52N1):c.803G>A(p.Gly268Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,298,904 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001913.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52N1 | NM_001001913.2 | c.803G>A | p.Gly268Glu | missense_variant | 2/2 | ENST00000641645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52N1 | ENST00000641645.1 | c.803G>A | p.Gly268Glu | missense_variant | 2/2 | NM_001001913.2 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-61-107776G>A | intron_variant | 1 | |||||
TRIM5 | ENST00000380027.5 | c.-441+67738G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000299 AC: 27AN: 90206Hom.: 1 Cov.: 24
GnomAD3 exomes AF: 0.0000864 AC: 17AN: 196744Hom.: 2 AF XY: 0.0000749 AC XY: 8AN XY: 106788
GnomAD4 exome AF: 0.0000124 AC: 15AN: 1208698Hom.: 2 Cov.: 31 AF XY: 0.00000833 AC XY: 5AN XY: 600478
GnomAD4 genome AF: 0.000299 AC: 27AN: 90206Hom.: 1 Cov.: 24 AF XY: 0.000342 AC XY: 15AN XY: 43860
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.803G>A (p.G268E) alteration is located in exon 1 (coding exon 1) of the OR52N1 gene. This alteration results from a G to A substitution at nucleotide position 803, causing the glycine (G) at amino acid position 268 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at